Skip NavigationSkip to Content

Anti-tumor and anti-metastatic roles of cordycepin, one bioactive compound of Cordyceps militaris

  1. Author:
    Jin, Ye
    Meng, Xue
    Qiu, Zhidong
    Su, Yanping
    Yu, Peng
    Qu, Peng
  2. Author Address

    Changchun Univ Chinese Med, Dept Pharm, 1035 Boshuo Rd, Changchun 130117, Jilin, Peoples R China.Taishan Med Coll, Dept Histol & Embryol, Tai An, Shandong, Peoples R China.NCI, NIH, Frederick, MD 21702 USA.
    1. Year: 2018
    2. Date: Jul
    3. Epub Date: 2018 05 14
  1. Journal: Saudi Journal of Biological Sciences
  2. ELSEVIER SCIENCE BV,
    1. 25
    2. 5
    3. Pages: 991-995
  3. Type of Article: Article
  4. ISSN: 1319-562X
  1. Abstract:

    Public interest in complementary and alternative medicine has been increased worldwide, due to its wide applications in cancer prevention and treatment. Cordycepin is one of the most common and crucial types of complementary and alternative medicine. Cordycepin (3'-deoxyadenosine), a derivative of adenosine, was first isolated from medicine drug Cordyceps militaris. Cordycepin has been widely used as one compound for antitumor, which has been found to exert antiangiogenic, anti-metastatic, and antiproliferative effects, as well as inducing apoptosis. However, the mechanism of its anti-tumor activity is not well known. This review will clarify anti-tumor mechanisms of Cordycepin, which regulate signaling pathways related with tumor growth and metastasis. Cordycepin inhibit tumor growth via upregulating tumor apoptosis, inducing cell cycle arrest and targeting cancer stem cells (CSCs). Cordycepin regulates tumor microenvironment via suppressing tumor metastasis-related pathways. Thus, Cordycepins may be one of important supplement or substitute medicine drug for cancer treatment. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

    See More

  1. Keywords:

External Sources

  1. DOI: 10.1016/j.sjbs.2018.05.016
  2. PMID: 30108453
  3. PMCID: PMC6088102
  4. WOS: 000437368700023

Library Notes

  1. Fiscal Year: FY2017-2018
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel